| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2007 | US20070196459 Compositions and methods for treating dermatitis or psoriasis |
| 08/23/2007 | US20070196454 Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices |
| 08/23/2007 | US20070196450 Delivery system for topical medications |
| 08/23/2007 | US20070196446 Conjugated fatty acid esters |
| 08/23/2007 | US20070196445 Method for the Prevention and Treatment of Cachexia and Anorexia |
| 08/23/2007 | US20070196444 Pantoprazole multiparticulate formulations |
| 08/23/2007 | US20070196443 Spherical core with enteric overcoating; antiulcer agents |
| 08/23/2007 | US20070196442 Method for improving the oral administration of alpha-lipoic acid |
| 08/23/2007 | US20070196440 Treatment methods requiring phyto-ingredients |
| 08/23/2007 | US20070196438 Compositions for the treatment of osteoarthritis and to nourish the synovial fluid |
| 08/23/2007 | US20070196437 Slowly digesting starch and fermentable fiber |
| 08/23/2007 | US20070196436 Process for preparing an edible composition comprising steroidal glycosides |
| 08/23/2007 | US20070196435 Drug and food or drink for improving hyperglycemia |
| 08/23/2007 | US20070196433 Methods and devices for the sustained release of multiple drugs |
| 08/23/2007 | US20070196428 Nitric oxide generating medical devices |
| 08/23/2007 | US20070196421 Soft tissue implants and drug combination compositions, and use thereof |
| 08/23/2007 | US20070196420 Fibers and yarns useful for constructing graft materials |
| 08/23/2007 | US20070196417 Therapeutic polyanhydride compounds for drug delivery |
| 08/23/2007 | US20070196407 Alkoxyphenylcarboxylic acid derivatives |
| 08/23/2007 | US20070196404 Laminates of chitosan films |
| 08/23/2007 | US20070196398 Fluoroquinolone fatty acid salt compositions |
| 08/23/2007 | US20070196396 Controlled release pharmaceutical compositions with improved bioavailability |
| 08/23/2007 | US20070196395 Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain |
| 08/23/2007 | US20070196393 Recombinant Neospora antigens and their uses |
| 08/23/2007 | US20070196385 Method of treating hepatitis C infection |
| 08/23/2007 | US20070196381 Herbal compositions, methods of stimulating immunomodulation and enhancement of immunomodulating agents using the herbal compositions |
| 08/23/2007 | US20070196377 polynucleotide; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection and treating stomach tumor; determining a disease, a pharmaceutical composition, and a reagent kit |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196367 Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system |
| 08/23/2007 | US20070196364 Pharmaceutical Formulation and Process |
| 08/23/2007 | US20070196361 Long term administration of pharmacologically active agents |
| 08/23/2007 | US20070196360 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors |
| 08/23/2007 | US20070196356 Topical bite care composition |
| 08/23/2007 | US20070196351 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 08/23/2007 | US20070196350 Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment |
| 08/23/2007 | US20070196347 Methods for preventing neurological events |
| 08/23/2007 | US20070196342 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects |
| 08/23/2007 | US20070196341 Preventive and/or remedy for inflammatory bowel diseases |
| 08/23/2007 | US20070196340 Modulation of Pathogenicity |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070196330 Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes |
| 08/23/2007 | US20070196329 Disinfection efficacy of lens care regimen for rigid gas permeable contact lenses |
| 08/23/2007 | US20070196328 Preservative for medical devices |
| 08/23/2007 | US20070196327 Nitric oxide releasing polymers |
| 08/23/2007 | US20070196326 Acryloyloxy-capped siloxane oligomer; copolymers with unsaturated monomers; antifouling coatings for underwater structures |
| 08/23/2007 | US20070196325 Compositions and methods for dermally treating infections |
| 08/23/2007 | US20070196324 Cellulite skin treatment methods and compositions |
| 08/23/2007 | US20070196323 Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs |
| 08/23/2007 | US20070196322 Method of preparing the colon for virtual colonoscopy |
| 08/23/2007 | US20070196321 In vivo stimulation of intestinal transporters for excretion of nitrogenous wastes |
| 08/23/2007 | US20070196316 Stimulation Of Hair Growth By Ginkgo Biloba Flavanoids |
| 08/23/2007 | US20070196314 topical emulsions, creams, lotions, gels, ointments or solutions comprising a mixture of cationic surfactants, anionic surfactants, chelate compounds, magnesium ascorbyl phosphate, vegetable oils and cucumber extracts, used for activating proteolytic enzymes on the epidermis and dermis; cosmetics |
| 08/23/2007 | US20070196293 Compositions and methods for treating photo damaged skin |
| 08/23/2007 | US20070196292 Personal care composition comprising dehydroacetate salts |
| 08/23/2007 | US20070196291 Cosmetic comprising a silicone polymer |
| 08/23/2007 | US20070196289 Use Of Licochalcone A Or Of An Extract Of Licochalcone A From Radix Glycyrrhizae Inflatae Against Skin Aging |
| 08/23/2007 | US20070196286 Aerosol composition comprising formoterol |
| 08/23/2007 | US20070196285 Novel combination of anticholinergics - B2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases |
| 08/23/2007 | US20070196283 Composition for transfection of DNA into the liver |
| 08/23/2007 | US20070196272 Oral delivery of therapeutic agents using tight junction agonists |
| 08/23/2007 | US20070196270 Compounds As Ccri Antagonists |
| 08/23/2007 | US20070196269 Pharmaceutical composition |
| 08/23/2007 | DE20023910U1 Pharmakologisch wirksame Substanz zur Behandlung kardiovasulärer Erkrankungen Pharmacologically active substance for treating diseases kardiovasulärer |
| 08/23/2007 | DE102007008231A1 Pharmazeutische Zubereitung zur Behandlung der Migräne A pharmaceutical preparation for the treatment of migraine |
| 08/23/2007 | DE102006008772A1 Hydroxymatairesinol gegen trockene Haut Hydroxymatairesinol dry skin |
| 08/23/2007 | DE102006008771A1 Gegen unreine Haut und milde Formen der Akne wirksame Zubereitungen mit einem Gehalt an Hydroxymatairesinol als wirksames Prinzip Against blemished skin and mild forms of acne effective preparations containing hydroxymatairesinol as the active principle |
| 08/23/2007 | DE102006008770A1 Verwendung von Hydroxymatairesinol zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen The use of hydroxymatairesinol for the preparation of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions |
| 08/23/2007 | DE102006008769A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Hydroxymatairesinol zur Hautaufhellung von Altersflecken bzw. zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung Cosmetic or dermatological preparations containing hydroxymatairesinol for skin lightening age spots or to avoid tanning of the skin, particularly caused by UV radiation tanning |
| 08/23/2007 | DE102006008730A1 Use of cosmetic or dermatological preparation in the form of oil-in-emulsion comprising hydroxymatairesinol for the tightening and/or strengthening of the skin, preferably for cellulite |
| 08/23/2007 | DE102006008074A1 Behandlung von Krebs mit Geruchsrezeptor-Liganden Treatment of cancer with olfactory receptor ligands |
| 08/23/2007 | DE102006007433A1 Adjuvanz in Form einer Lipid-modifizierten Nukleinsäure Adjuvant in the form of a lipid-modified nucleic acid |
| 08/23/2007 | DE102006007245A1 Implantatmaterial Implant material |
| 08/23/2007 | DE102006007146A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 08/23/2007 | DE102006006648A1 Mandelsäurehydrazide Mandelsäurehydrazide |
| 08/23/2007 | DE102006005861A1 Substituierte Chinolone III Substituted Quinolones III |
| 08/23/2007 | DE102005062417A1 Kompositionen mit spezifischen und unspezifischen Lipidantagonisten Compositions with specific and nonspecific lipid antagonists |
| 08/23/2007 | CA2657674A1 The application of glycyrrhizic acid and its breakdown product glycyrrhetinic acid for the manufacture of a medicament for the treatment of inflammatory bowel disease |
| 08/23/2007 | CA2652648A1 Dihydrodiazepines useful as inhibitors of protein kinases |
| 08/23/2007 | CA2645734A1 Method of treating inflammatory diseases |
| 08/23/2007 | CA2642850A1 Combination of alpha-2 receptor agonist (clonidine)and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 08/23/2007 | CA2642754A1 Compositions and methods for antibiotic potentiation and drug discovery |
| 08/23/2007 | CA2642751A1 Proteasom or ups inhibitor for treating infections with influenza viruses |
| 08/23/2007 | CA2642738A1 Pi-3 kinase inhibitors and methods of their use |
| 08/23/2007 | CA2642668A1 Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (sip) receptor antagonist biological activity |
| 08/23/2007 | CA2642641A1 Stable corticosteroid mixtures |
| 08/23/2007 | CA2642583A1 Boron-containing small molecules as anti-inflammatory agents |
| 08/23/2007 | CA2642581A1 Method for accelerating reentrainment of a circadian rhythm |
| 08/23/2007 | CA2642579A1 Sterilization of corticosteroids with reduced mass loss |
| 08/23/2007 | CA2642572A1 Plasma from vitiligo patients for treatment of melanoma |
| 08/23/2007 | CA2642561A1 Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions |
| 08/23/2007 | CA2642524A1 External preparation for skin containing flavanone derivative |
| 08/23/2007 | CA2642483A1 Heterocyclic antiviral compounds |
| 08/23/2007 | CA2642453A1 Methoxypolyethylene glycol thioester chelate and uses thereof |
| 08/23/2007 | CA2642414A1 Rapid release irbesartan-containing pharmaceutical composition |
| 08/23/2007 | CA2642406A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 08/23/2007 | CA2642338A1 Adhesive preparation comprising sufentanil and methods of using the same |
| 08/23/2007 | CA2642297A1 Substituted cyclohexyl carboxamide modulators of trp-p8 activity |
| 08/23/2007 | CA2642275A1 Stable dosage formulations of imidazolylalkyl-pyridines |
| 08/23/2007 | CA2642266A1 Mitotic progression genes and methods of modulating mitosis |
| 08/23/2007 | CA2642260A1 Intravenous antiviral treatments |